An update on potential therapeutic strategies for Parkinson’s disease based on pathogenic mechanisms
出版年份 2016 全文链接
标题
An update on potential therapeutic strategies for Parkinson’s disease based on pathogenic mechanisms
作者
关键词
-
出版物
Expert Review of Neurotherapeutics
Volume 16, Issue 6, Pages 711-722
出版商
Informa UK Limited
发表日期
2016-05-03
DOI
10.1080/14737175.2016.1179112
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Long-Term Safety of Patients with Parkinson's Disease Receiving rAAV2-Neurturin (CERE-120) Gene Transfer
- (2016) William J. Marks et al. HUMAN GENE THERAPY
- A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies
- (2016) Dante J. Marciani JOURNAL OF NEUROCHEMISTRY
- A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease
- (2016) Chi-Jing Choong et al. NEUROBIOLOGY OF AGING
- The genetics of Parkinson's disease
- (2015) Stephen Mullin et al. BRITISH MEDICAL BULLETIN
- SnapShot: Genetics of Parkinson’s Disease
- (2015) José Brás et al. CELL
- Successful Function of Autologous iPSC-Derived Dopamine Neurons following Transplantation in a Non-Human Primate Model of Parkinson’s Disease
- (2015) Penelope J. Hallett et al. Cell Stem Cell
- Human olfactory bulb neural stem cells mitigate movement disorders in a rat model of Parkinson's disease
- (2015) Hany E.S. Marei et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hepatitis C virus infection: a risk factor for Parkinson's disease
- (2015) W. Y.-Y. Wu et al. JOURNAL OF VIRAL HEPATITIS
- Disease-modifying strategies for Parkinson's disease
- (2015) Lorraine V. Kalia et al. MOVEMENT DISORDERS
- Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis
- (2015) Jennifer T. Lamberts et al. NEUROBIOLOGY OF DISEASE
- The association between infectious burden and Parkinson's disease: A case-control study
- (2015) Xian-Le Bu et al. PARKINSONISM & RELATED DISORDERS
- Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease
- (2015) Chun-Hyung Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induced neural stem/precursor cells for fundamental studies and potential application in neurodegenerative diseases
- (2015) Ting Shen et al. Neuroscience Bulletin
- Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
- (2015) Ruth Brauer et al. PLOS MEDICINE
- The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
- (2014) Johannes Levin et al. ACTA NEUROPATHOLOGICA
- Targeting alpha-synuclein with a microRNA-embedded silencing vector in the rat substantia nigra: Positive and negative effects
- (2014) Christina E. Khodr et al. BRAIN RESEARCH
- Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study
- (2014) Ursula Unterberger et al. CLINICAL NEUROPATHOLOGY
- Genetic Insights into Sporadic Parkinson's Disease Pathogenesis
- (2014) Chou Chai et al. CURRENT GENOMICS
- Challenges and Promises in the Development of Neurotrophic Factor-Based Therapies for Parkinson’s Disease
- (2014) Tiago Martins Rodrigues et al. DRUGS & AGING
- How Epigallocatechin Gallate Can Inhibit α-Synuclein Oligomer Toxicityin Vitro
- (2014) Nikolai Lorenzen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Direct Conversion of Human Fibroblasts into Neuronal Restricted Progenitors
- (2014) Qingjian Zou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases
- (2014) Jing L Guo et al. NATURE MEDICINE
- Direct conversion of mouse fibroblasts into induced neural stem cells
- (2014) Sung Min Kim et al. Nature Protocols
- The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse
- (2014) Mari H. Savolainen et al. NEUROBIOLOGY OF DISEASE
- Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread
- (2014) Gabor G. Kovacs et al. NEUROBIOLOGY OF DISEASE
- Correction: Scale Determinants of Fiscal Investment in Geological Exploration: Evidence from China
- (2014) Linna Lu et al. PLoS One
- Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease
- (2014) Gergely Tóth et al. PLoS One
- Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations
- (2014) Vinay K. Godena et al. Nature Communications
- Safinamide for the treatment of Parkinson’s disease
- (2014) Rukmini Mridula Kandadai et al. Expert Review of Clinical Pharmacology
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
- (2013) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys
- (2013) Ariadna Recasens et al. ANNALS OF NEUROLOGY
- The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease
- (2013) A.R. Esteves et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- α-Synuclein: The Long Distance Runner
- (2013) Sonia George et al. BRAIN PATHOLOGY
- Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF
- (2013) A. P. Kells et al. JOURNAL OF NEUROSCIENCE
- Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
- (2013) Goran Laćan et al. JOURNAL OF NEUROSCIENCE RESEARCH
- NURR1 in Parkinson disease—from pathogenesis to therapeutic potential
- (2013) Mickael Decressac et al. Nature Reviews Neurology
- Gene-based Therapies in Parkinson’s Disease
- (2013) Patricia J. Allen et al. Neurotherapeutics
- Conversion of Human Umbilical Cord Mesenchymal Stem Cells in Wharton’s Jelly to Dopamine Neurons Mediated by the Lmx1a and Neurturin In Vitro: Potential Therapeutic Application for Parkinson’s Disease in a Rhesus Monkey Model
- (2013) Min Yan et al. PLoS One
- S-nitrosylation regulates mitochondrial quality control via activation of parkin
- (2013) Kentaro Ozawa et al. Scientific Reports
- Induced Pluripotent Stem Cell-Derived Neural Cells Survive and Mature in the Nonhuman Primate Brain
- (2013) Marina E. Emborg et al. Cell Reports
- Long-term Clinical Outcome of Fetal Cell Transplantation for Parkinson Disease
- (2013) Zinovia Kefalopoulou et al. JAMA Neurology
- The prion hypothesis in Parkinson's disease: Braak to the future
- (2013) Naomi P Visanji et al. Acta Neuropathologica Communications
- Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models
- (2012) Thomas Kramer et al. ACS Chemical Neuroscience
- A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease
- (2012) TT Myöhänen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mao-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: protective effects of rapamycin
- (2012) Almas Siddiqui et al. FREE RADICAL RESEARCH
- Infectious Agents and Neurodegeneration
- (2012) Giovanna De Chiara et al. MOLECULAR NEUROBIOLOGY
- Pathogenesis of Parkinson's disease
- (2012) Etienne C. Hirsch et al. MOVEMENT DISORDERS
- 70 AFFITOPE® — based vaccines: results from phase I support the further clinical development of AFFITOPE® AD02
- (2012) Achim Schneeberger et al. NEUROBIOLOGY OF AGING
- The histone deacetylase inhibitor, sodium butyrate, alleviates cognitive deficits in pre-motor stage PD
- (2012) Pallavi Rane et al. NEUROPHARMACOLOGY
- Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
- (2012) Mark L. Wahlqvist et al. PARKINSONISM & RELATED DISORDERS
- Dopaminergic Neurons from Midbrain-Specified Human Embryonic Stem Cell-Derived Neural Stem Cells Engrafted in a Monkey Model of Parkinson’s Disease
- (2012) Marcel M. Daadi et al. PLoS One
- Small Molecule c-jun-N-Terminal Kinase Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson’s Disease
- (2011) Jeremy W. Chambers et al. ACS Chemical Neuroscience
- A microRNA embedded AAV alpha-synuclein gene silencing vector for dopaminergic neurons
- (2011) Ye Han et al. BRAIN RESEARCH
- An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons
- (2011) Christina E. Khodr et al. BRAIN RESEARCH
- Functional Integration of Dopaminergic Neurons Directly Converted from Mouse Fibroblasts
- (2011) Jongpil Kim et al. Cell Stem Cell
- Diabetes and Risk of Parkinson's Disease: A systematic review and meta-analysis
- (2011) E. Cereda et al. DIABETES CARE
- Pathways towards an effective immunotherapy for Parkinson’s disease
- (2011) Jessica AL Hutter-Saunders et al. Expert Review of Neurotherapeutics
- Cell-based therapies for Parkinson’s disease
- (2011) Sean C Dyson et al. Expert Review of Neurotherapeutics
- AFFITOME® technology in neurodegenerative diseases: The doubling advantage
- (2011) Achim Schneeberger et al. Human vaccines & immunotherapeutics
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model
- (2011) A.R. Carta et al. NEUROSCIENCE
- Immunization strategies for Parkinson's disease
- (2011) Duy Ha et al. PARKINSONISM & RELATED DISORDERS
- Vaccination for Parkinson's disease
- (2011) A. Schneeberger et al. PARKINSONISM & RELATED DISORDERS
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- α-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra
- (2010) Alison L. McCormack et al. PLoS One
- Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
- (2010) H. S. Ko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- c-Jun N-terminal kinase (JNK) signaling: Recent advances and challenges
- (2009) Marie A. Bogoyevitch et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death
- (2009) Kaoru Saijo et al. CELL
- Safety Evaluation of AAV2-GDNF Gene Transfer into the Dopaminergic Nigrostriatal Pathway in Aged and Parkinsonian Rhesus Monkeys
- (2009) Xiaomin Su et al. HUMAN GENE THERAPY
- Development of AFFITOPE vaccines for Alzheimer’s disease (AD) — From concept to clinical testing
- (2009) A. Schneeberger et al. Journal of Nutrition Health & Aging
- Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
- (2009) C. W. Christine et al. NEUROLOGY
- Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease
- (2009) Neelam K. Venkataramana et al. Translational Research
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years
- (2008) Ivar Mendez et al. NATURE MEDICINE
- Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
- (2008) J. L. Eberling et al. NEUROLOGY
- Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: Autonomic pathway implicated in Parkinson's disease?
- (2008) R.J. Phillips et al. NEUROSCIENCE
- Human Embryonic Stem Cell-Derived Dopaminergic Neurons Reverse Functional Deficit in Parkinsonian Rats
- (2007) Dali Yang et al. STEM CELLS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started